21 U.S.C. § 399j: Abraham Accords Office

Summary

Create an Abraham Accords Office inside the Food and Drug Administration, led by a director. Not later than 2 years after February 3, 2026, the Secretary must pick a site in an Abraham Accords country, set up the office there after talking with those governments and U.S. diplomatic and security staff, and assign FDA staff needed to run it. The office must help Abraham Accords countries improve and align rules for products the FDA regulates. It will give technical help on manufacturing and oversight, share information about U.S. regulatory pathways, and gather feedback on research, development, and manufacturing. The Secretary can give it other tasks as needed. An Abraham Accords country is one the State Department says signed the Abraham Accords Declaration. Nothing here requires action that conflicts with a federal national security recommendation.

Title 21, §399j

Food and Drugs, Source: USLM XML via OLRC

(a)In general

The Secretary, acting through the Commissioner of Food and Drugs, shall establish within the Food and Drug Administration an office, to be known as the Abraham Accords Office, to be headed by a director.

(b)Office

Not later than 2 years after February 3, 2026, the Secretary shall—

(1)in consultation with the governments of Abraham Accords countries, as well as appropriate United States Government diplomatic and security personnel—

(A)select the location of the Abraham Accords Office in an Abraham Accords country; and

(B)establish such office; and

(2)assign to such office such personnel of the Food and Drug Administration as the Secretary determines necessary to carry out the functions of such office.

(c)Duties

The Secretary, acting through the Director of the Abraham Accords Office, shall—

(1)after the Abraham Accords Office is established—

(A)as part of the Food and Drug Administration’s work to strengthen the international oversight of regulated commodities, provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices and other issues relevant to manufacturing medical products that are regulated by the Food and Drug Administration; and

(B)facilitate interactions between the Food and Drug Administration and interested parties in Abraham Accords countries, including by sharing relevant information regarding United States regulatory pathways with such parties, and facilitate feedback on the research, development, and manufacturing of products regulated in accordance with this chapter; and

(2)carry out other functions and activities as the Secretary determines to be necessary to carry out this section.

(d)Abraham Accords country defined

In this section, the term “Abraham Accords country” means a country identified by the Department of State as having signed the Abraham Accords Declaration.

(e)National security

Nothing in this section shall be construed to require any action inconsistent with a national security recommendation provided by the Federal Government.

§399j Abraham Accords Office

Summary

Title 21, §399j

Notes & Related Subsidiaries

Editorial Notes

Citations & Metadata